Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.

by Keiichi Kondo, William Y Kim, Mirna Lechpammer, William G Kaelin
Published 2003-12-01

Mouse Reporter Strain for Noninvasive Bioluminescent Imaging of Cells that have Undergone Cre-Mediated Recombination

by Michal Safran, William Y. Kim, Andrew L. Kung, James W. Horner, Ron A. DePinho, William G. Kaelin
Published 2003-10-01

mTOR inhibition induces compensatory, therapeutically targetable MEK activation in renal cell carcinoma.

by Sean T Bailey, Bing Zhou, Jeffrey S Damrauer, Bhavani Krishnan, Harper L Wilson, Aleisha M Smith, Mingqing Li, Jen Jen Yeh, William Y Kim
Published 2014-01-01

Development and validation of a NanoString BASE47 bladder cancer gene classifier.

by Jordan Kardos, Tracy L Rose, Ujjawal Manocha, Sara E Wobker, Jeffrey S Damrauer, Trinity J Bivalaqua, Max Kates, Kristin J Moore, Joel S Parker, William Y Kim
Published 2020-01-01

Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.

by Denis R Beckford Vera, Christof C Smith, Lisa M Bixby, Dylan M Glatt, Stuart S Dunn, Ryoichi Saito, William Y Kim, Jonathan S Serody, Benjamin G Vincent, Matthew C Parrott
Published 2018-01-01

MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression

by Yao Jiang, Yanqiong Zhang, Janet Y. Leung, Cheng Fan, Konstantin I. Popov, Siyuan Su, Jiayi Qian, Xiaodong Wang, Alisha Holtzhausen, Eric Ubil, Yang Xiang, Ian Davis, Nikolay V. Dokholyan, Gang Wu, Charles M. Perou, William Y. Kim, H. Shelton Earp, Pengda Liu
Published 2019-04-01

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma

by Christopher G. Wood, James E. Ferguson III, Joel S. Parker, Dominic T. Moore, Jennifer G. Whisenant, Susan J. Maygarden, Eric M. Wallen, William Y. Kim, Mathew I. Milowsky, Kathryn E. Beckermann, Nancy B. Davis, Scott M. Haake, Jose A. Karam, Dante S. Bortone, Benjamin G. Vincent, Thomas Powles, W. Kimryn Rathmell
Published 2020-11-01

MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma

by Sean T. Bailey, Aleisha M. Smith, Jordan Kardos, Sara E. Wobker, Harper L. Wilson, Bhavani Krishnan, Ryoichi Saito, Hyo Jin Lee, Jing Zhang, Samuel C. Eaton, Lindsay A. Williams, Ujjawal Manocha, Dorien J. Peters, Xinchao Pan, Thomas J. Carroll, Dean W. Felsher, Vonn Walter, Qing Zhang, Joel S. Parker, Jen Jen Yeh, Richard A. Moffitt, Janet Y. Leung, William Y. Kim
Published 2017-06-01